Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].
作者信息
Wang Wei-Wei, Zhao Zhi-Hua, Wang Li, Li Pan, Chen Kui-Sheng, Zhang Jian-Ying, Li Wen-Cai, Jiang Guo-Zhong, Li Xiang-Nan
机构信息
Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
出版信息
EBioMedicine. 2024 May;103:105106. doi: 10.1016/j.ebiom.2024.105106. Epub 2024 Apr 4.
Abstract
摘要
相似文献
1
Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].撤回声明：“《对〈MicroRNA-134通过PLXNA1介导的MAPK信号通路预防食管鳞状细胞癌进展〉的勘误》[《E生物医学》46 (2019) 66 - 78]”[《E生物医学》55 (2020) 102772]
EBioMedicine. 2024 May;103:105106. doi: 10.1016/j.ebiom.2024.105106. Epub 2024 Apr 4.
2
Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].《关于“MicroRNA-134通过PLXNA1介导的MAPK信号通路抑制食管鳞状细胞癌进展”的撤稿声明》[《电子生物医学》46 (2019) 66 - 78]
EBioMedicine. 2024 May;103:105105. doi: 10.1016/j.ebiom.2024.105105. Epub 2024 Apr 4.
3
Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].《“MicroRNA-134通过PLXNA1介导的MAPK信号通路阻止食管鳞状细胞癌进展”的勘误》[《电子生物医学》46 (2019) 66 - 78]
EBioMedicine. 2020 May;55:102772. doi: 10.1016/j.ebiom.2020.102772. Epub 2020 May 21.
4
MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.微小 RNA-134 通过 PLXNA1 介导的 MAPK 信号通路抑制食管鳞癌细胞的进展。
EBioMedicine. 2019 Aug;46:66-78. doi: 10.1016/j.ebiom.2019.07.050. Epub 2019 Aug 2.
5
Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].撤回通知：“LSAMP-AS1通过上调肿瘤抑制因子DCN与微小RNA-183-5p结合以抑制前列腺癌进展”[《电子生物医学》50 (2019) 178 - 190]
EBioMedicine. 2021 Oct;72:103665. doi: 10.1016/j.ebiom.2021.103665.
6
Retraction notice to "LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN" [EBioMedicine 44 (2019) 298-310].撤回通知：“LINC00184沉默通过PTEN去甲基化抑制食管癌糖酵解并恢复线粒体氧化磷酸化”[《电子生物医学》44卷（2019年）第298 - 310页]
EBioMedicine. 2024 Jun;104:105192. doi: 10.1016/j.ebiom.2024.105192. Epub 2024 Jun 3.
7
Retraction Notice to 'MiR-15a-5p targets FOSL1 to inhibit proliferation and promote apoptosis of keratinocytes via MAPK/ERK pathway' [J Tissue Viability 30/4 (2021) 544-551].撤回通知：“MiR-15a-5p通过MAPK/ERK途径靶向FOSL1以抑制角质形成细胞增殖并促进其凋亡”[《组织活力杂志》30/4 (2021) 544 - 551]
J Tissue Viability. 2022 Nov;31(4):808. doi: 10.1016/j.jtv.2022.07.001. Epub 2022 Aug 16.
8
Retraction notice to "Corrigendum to 'LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway'" [Biomed. Pharmacother. 111 (2019) 1508-1508].
Biomed Pharmacother. 2024 Apr;173:116327. doi: 10.1016/j.biopha.2024.116327. Epub 2024 Mar 5.
9
Retraction notice to 'Neurotensin contributes to pediatric intestinal failure-associated liver disease via regulating intestinal bile acids uptake': [EBioMedicine 35 (2018) 133-141].撤回关于“神经降压素通过调节肠道胆汁酸摄取促进小儿肠衰竭相关肝病”的通知：[《转化医学杂志》35卷（2018年）第133 - 141页]
EBioMedicine. 2020 Jul;57:102927. doi: 10.1016/j.ebiom.2020.102927.
10
Corrigendum to "A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma" [EBioMedicine 41 (2019) 244-255].《“一种PLK1激酶抑制剂通过诱导食管鳞状细胞癌焦亡增强顺铂化疗敏感性”的勘误》[《电子生物医学》41卷（2019年）第244 - 255页]
EBioMedicine. 2019 May;43:650. doi: 10.1016/j.ebiom.2019.05.001. Epub 2019 May 14.
Zotero 插件